Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Melanoma Stage IV”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT05913388
What this trial is testing

GB1211 and Pembrolizumab Versus Pembrolizumab and Placebo in Patients With Metastatic Melanoma and Head and Neck Squamous Cell Carcinoma

Who this might be right for
Metastatic MelanomaHead and Neck Squamous Cell Carcinoma
Providence Health & Services 12
Testing effectiveness (Phase 2)Study completedNCT00019396
What this trial is testing

Flt3L With or Without Vaccine Therapy in Treating Patients With Metastatic Melanoma or Renal Cell Cancer

Who this might be right for
Stage IV MelanomaStage IV Renal Cell CancerRecurrent Renal Cell Cancer+1 more
National Cancer Institute (NCI)
Early research (Phase 1)Study completedNCT01271803
What this trial is testing

Vemurafenib and GDC-0973 (Cobimetinib) in Participants With BRAFV600E Mutation-Positive Metastatic Melanoma

Who this might be right for
Malignant Melanoma
Hoffmann-La Roche 131
Testing effectiveness (Phase 2)Study completedNCT01807182
What this trial is testing

Tumor-Infiltrating Lymphocytes After Combination Chemotherapy in Treating Patients With Metastatic Melanoma

Who this might be right for
Stage III Cutaneous Melanoma AJCC v7Stage IIIA Cutaneous Melanoma AJCC v7Stage IIIB Cutaneous Melanoma AJCC v7+3 more
Fred Hutchinson Cancer Center 11
Early research (Phase 1)Active Not RecruitingNCT02298959
What this trial is testing

Testing the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced Cancer

Who this might be right for
Clinical Stage IV Cutaneous Melanoma AJCC v8Metastatic Colorectal CarcinomaMetastatic Malignant Solid Neoplasm+12 more
National Cancer Institute (NCI) 59
Early research (Phase 1)Ended earlyNCT00571116
What this trial is testing

Disulfiram Plus Arsenic Trioxide In Patients With Metastatic Melanoma and at Least One Prior Systemic Therapy

Who this might be right for
Metastatic Melanoma
University of California, Irvine 9
Testing effectiveness (Phase 2)WithdrawnNCT04129515
What this trial is testing

NovoTTF-200A + Pembrolizumab In Melanoma Brain Metastasis

Who this might be right for
Metastatic MelanomaMelanoma Brain Metastasis
Brown University
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07576725
What this trial is testing

Low Dose, Reduced Frequency Nivolumab for the Treatment of Unresectable or Metastatic Cancer, AFFORD IO Trial

Who this might be right for
Clinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage III Cutaneous Merkel Cell Carcinoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8+40 more
Fred Hutchinson Cancer Center 50
Testing effectiveness (Phase 2)Ended earlyNCT03684785
What this trial is testing

Intratumoral Cavrotolimod Combined With Pembrolizumab or Cemiplimab in Patients With Merkel Cell Carcinoma, Cutaneous Squamous Cell Carcinoma, or Other Advanced Solid Tumors

Who this might be right for
Advanced or Metastatic Merkel Cell CarcinomaAdvanced or Metastatic Cutaneous Squamous Cell CarcinomaAdvanced or Metastatic Melanoma+2 more
Exicure, Inc. 57
Very early researchStudy completedNCT03784625
What this trial is testing

Targeted Radionuclide Therapy for Metastatic Melanoma [131I] ICF01012

Who this might be right for
Melanoma
Centre Jean Perrin 10
Large-scale testing (Phase 3)Study completedNCT00287196
What this trial is testing

Immediate Radiotherapy or Observation After Surgery for Melanoma Involving Lymph Nodes

Who this might be right for
Malignant MelanomaLymph Node Disease
Trans Tasman Radiation Oncology Group 250
Testing effectiveness (Phase 2)Looking for participantsNCT06295159
What this trial is testing

Neoadjuvant and Adjuvant Anti-PD1 or Combinations for Locoregionally Advanced Melanoma

Who this might be right for
Melanoma Stage IIIMelanoma Stage IVAdvanced Melanoma+1 more
H. Lee Moffitt Cancer Center and Research Institute 90
Testing effectiveness (Phase 2)Study completedNCT00665470
What this trial is testing

Chemotherapy Followed by gp100 Lymphocytes and Aldesleukin to Treat Melanoma

Who this might be right for
Skin CancerMetastatic Melanoma
National Cancer Institute (NCI) 10
Early research (Phase 1)Looking for participantsNCT07086105
What this trial is testing

Evaluate Adze1.C in Participants With Metastatic Melanoma

Who this might be right for
Metastatic Melanoma
Adze Biotechnology Australia Pty Ltd 30
Early research (Phase 1)Ended earlyNCT00003060
What this trial is testing

Chemotherapy Plus Bone Marrow Transplantation in Treating Patients With Metastatic Melanoma

Who this might be right for
Melanoma (Skin)
Louisiana State University Health Sciences Center Shreveport 6
Testing effectiveness (Phase 2)Ended earlyNCT01009515
What this trial is testing

Carboplatin, Paclitaxel, and Temozolomide for Patients With Metastatic Melanoma

Who this might be right for
Melanoma
New Mexico Cancer Research Alliance 19
Early research (Phase 1)Ended earlyNCT01585415
What this trial is testing

Vemurafenib and White Blood Cell Therapy for Advanced Melanoma

Who this might be right for
Metastatic CancerMelanoma
National Cancer Institute (NCI) 12
Testing effectiveness (Phase 2)Study completedNCT00602576
What this trial is testing

Temozolomide and Sorafenib in Treating Patients With Metastatic or Unresectable Melanoma

Who this might be right for
Melanoma (Skin)
Abramson Cancer Center at Penn Medicine 169
Testing effectiveness (Phase 2)Ended earlyNCT00724841
What this trial is testing

A Phase I/II Study of GMX1777 in Combination With Temozolomide for the Treatment of Metastatic Melanoma

Who this might be right for
Metastatic Melanoma
Gemin X 1
Testing effectiveness (Phase 2)Study completedNCT00598507
What this trial is testing

Phase II Trial Of ZK-EPO (ZK 219477) (Sagopilone) In Metastatic Melanoma

Who this might be right for
Melanoma
H. Lee Moffitt Cancer Center and Research Institute 35
Next Page